167 related articles for article (PubMed ID: 30033040)
1. Postural orthostatic tachycardia syndrome and the potential role of mast cell activation.
Doherty TA; White AA
Auton Neurosci; 2018 Dec; 215():83-88. PubMed ID: 30033040
[TBL] [Abstract][Full Text] [Related]
2. Association of Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome with Mast Cell Activation Disorders.
Bonamichi-Santos R; Yoshimi-Kanamori K; Giavina-Bianchi P; Aun MV
Immunol Allergy Clin North Am; 2018 Aug; 38(3):497-504. PubMed ID: 30007466
[TBL] [Abstract][Full Text] [Related]
3. Dysautonomia, Hypermobility Spectrum Disorders and Mast Cell Activation Syndrome as Migraine Comorbidities.
Blitshteyn S
Curr Neurol Neurosci Rep; 2023 Nov; 23(11):769-776. PubMed ID: 37847487
[TBL] [Abstract][Full Text] [Related]
4. Selective Response to Omalizumab in a Patient With Concomitant ncMCAS and POTS: What Does it Teach us About the Underlying Disease?
Kacar M; Denman S; Savic S
J Investig Allergol Clin Immunol; 2018 Aug; 28(4):261-263. PubMed ID: 30073959
[No Abstract] [Full Text] [Related]
5. Mast Cell Activation Disorder and Postural Orthostatic Tachycardia Syndrome: A Clinical Association.
Kohno R; Cannom DS; Olshansky B; Xi SC; Krishnappa D; Adkisson WO; Norby FL; Fedorowski A; Benditt DG
J Am Heart Assoc; 2021 Sep; 10(17):e021002. PubMed ID: 34398691
[TBL] [Abstract][Full Text] [Related]
6. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort.
Reynolds GK; Lewis DP; Richardson AM; Lidbury BA
J Intern Med; 2014 Apr; 275(4):409-17. PubMed ID: 24206536
[TBL] [Abstract][Full Text] [Related]
7. Postural orthostatic tachycardia syndrome (POTS): association with Ehlers-Danlos syndrome and orthopaedic considerations.
Grigoriou E; Boris JR; Dormans JP
Clin Orthop Relat Res; 2015 Feb; 473(2):722-8. PubMed ID: 25156902
[TBL] [Abstract][Full Text] [Related]
8. Postural Tachycardia Syndrome: Beyond Orthostatic Intolerance.
Garland EM; Celedonio JE; Raj SR
Curr Neurol Neurosci Rep; 2015 Sep; 15(9):60. PubMed ID: 26198889
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of postural orthostatic tachycardia and mast cell activation syndromes using naltrexone, immunoglobulin and antibiotic treatment.
Weinstock LB; Brook JB; Myers TL; Goodman B
BMJ Case Rep; 2018 Jan; 2018():. PubMed ID: 29326369
[TBL] [Abstract][Full Text] [Related]
10. Cosegregation of postural orthostatic tachycardia syndrome, hypermobile Ehlers-Danlos syndrome, and mast cell activation syndrome.
Vadas P; Guzman J; McGillis L; Mittal N; Walsh S
Ann Allergy Asthma Immunol; 2020 Dec; 125(6):719-720. PubMed ID: 32798618
[No Abstract] [Full Text] [Related]
11. Postural Tachycardia Syndrome (POTS) and the GI Tract: A Primer for the Gastroenterologist.
DiBaise JK; Harris LA; Goodman B
Am J Gastroenterol; 2018 Oct; 113(10):1458-1467. PubMed ID: 30072778
[TBL] [Abstract][Full Text] [Related]
12. Increased prevalence of autonomic dysfunction due to postural orthostatic tachycardia syndrome in patients with eosinophilic gastrointestinal disorders.
Huang KZ; Dellon ES
J Gastrointestin Liver Dis; 2019 Mar; 28(1):47-51. PubMed ID: 30851172
[TBL] [Abstract][Full Text] [Related]
13. [Postural orthostatic tachycardia syndrome (POTS)--pathophysiology, diagnostics, and treatment].
Rek M; Kaczmarek K; Cygankiewicz I; Wranicz JK; Ptaszyński P
Przegl Lek; 2014; 71(8):450-3. PubMed ID: 25546918
[TBL] [Abstract][Full Text] [Related]
14. Postural Orthostatic Tachycardia Syndrome: JACC Focus Seminar.
Bryarly M; Phillips LT; Fu Q; Vernino S; Levine BD
J Am Coll Cardiol; 2019 Mar; 73(10):1207-1228. PubMed ID: 30871704
[TBL] [Abstract][Full Text] [Related]
15. [Postural tachycardia syndrome (PoTS): An up-to-date].
Astudillo L; Laure A; Fabry V; Pugnet G; Maury P; Labrunée M; Sailler L; Pavy-Le Traon A
Rev Med Interne; 2018 Aug; 39(8):627-634. PubMed ID: 29909001
[TBL] [Abstract][Full Text] [Related]
16. Postural Orthostatic Tachycardia Syndrome (POTS)--A novel member of the autoimmune family.
Dahan S; Tomljenovic L; Shoenfeld Y
Lupus; 2016 Apr; 25(4):339-42. PubMed ID: 26846691
[TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for postural tachycardia syndrome.
Miller AJ; Raj SR
Auton Neurosci; 2018 Dec; 215():28-36. PubMed ID: 29753556
[TBL] [Abstract][Full Text] [Related]
18. Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome.
Roerink ME; Lenders JW; Schmits IC; Pistorius AM; Smit JW; Knoop H; van der Meer JW
J Intern Med; 2017 Feb; 281(2):179-188. PubMed ID: 27696568
[TBL] [Abstract][Full Text] [Related]
19. Dysautonomia and Headache in the Pediatric Population.
Wig R; Oakley CB
Headache; 2019 Oct; 59(9):1582-1588. PubMed ID: 31549738
[TBL] [Abstract][Full Text] [Related]
20. Postural orthostatic tachycardia syndrome in children and adolescents.
Boris JR
Auton Neurosci; 2018 Dec; 215():97-101. PubMed ID: 29778304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
